VALNEVA to Present on Lyme and Chikungunya Vaccine Candidates at the 19th World Vaccine Congress
by Press Release from Outbreak News Today on (#4CVFG)
Valneva SE, a biotech company developing and commercializing vaccines for infectious diseases with major unmet needs, announced today it will present on its Lyme disease and chikungunya vaccine candidates on April 16th, 2019 at the 19th World Vaccine Congress in Washington, D.C. Valneva's Chief Executive Officer, Thomas Lingelbach, will provide an update and discuss next ["]
The post VALNEVA to Present on Lyme and Chikungunya Vaccine Candidates at the 19th World Vaccine Congress appeared first on Outbreak News Today.